Ambuja Cements Ltd (AMBUJACEM) — Corporate Action | 27 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Ambuja Cements convened a court-ordered shareholders' meeting to approve the ACC amalgamation scheme.
🔄 What Changed
Approval of the Scheme of Amalgamation and authorization of the Board to implement it
🔮 What's Next
Results to be announced by October 1, 2026, subject to NCLT approval
💡 Investor Takeaway
Shareholders must vote to approve the merger, which will consolidate ACC into Ambuja Cements without dilution except for share cancellation and new issuance.

Ambuja Cements convened a court-ordered shareholders' meeting on September 29, 2026, to approve the amalgamation of ACC Limited into Ambuja Cements. Shareholders can vote remotely via e-voting from September 24 to 28, 2026, with results to be announced by October 1, 2026. The scheme requires majority approval by value, including specific approval from public shareholders. Mr. Deep Chandra Joshi will chair the meeting, and all assets, liabilities, contracts, and IP of ACC will automatically transfer to Ambuja Cements upon effectiveness. The merger aims to consolidate ownership, eliminate duplication, and create operational synergies under a unified structure.

📄 View Original Announcement (PDF)

About Ambuja Cements Ltd (AMBUJACEM)

Construction Materials · Cement · Listed on BSE

Market Cap: ₹1,00,063.59 Cr P/E: 22.6 ROE: 8.8% ROCE: 4.9% Div Yield: 0.50%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMBUJACEM — Free

Free account · 2 AI queries/day